Clinical trial design in the neurocritical care unit

C. E. Hall, M. Mirski, Y. Y. Palesch, M. N. Diringer, A. I. Qureshi, C. S. Robertson, R. Geocadin, C. A.C. Wijman, P. D. Le Roux, Jose I. Suarez

Research output: Contribution to journalReview article

7 Scopus citations

Abstract

Clinical trials provide a robust mechanism to advance science and change clinical practice across the widest possible spectrum. Fundamental in the Neurocritical Care Society's mission is to promote Quality Patient Care by identifying and implementing best medical practices for acute neurological disorders that are consistent with the current scientific knowledge. The next logical step will be to foster rapid growth of our scientific body of evidence, to establish and disseminate these best practices. In this manuscript, five invited experts were impaneled to address questions, identified by the conference organizing committee as fundamental issues for the design of clinical trials in the neurological intensive care unit setting.

Original languageEnglish (US)
Pages (from-to)6-19
Number of pages14
JournalNeurocritical Care
Volume16
Issue number1
DOIs
StatePublished - Feb 1 2012

Keywords

  • Funding
  • Industry
  • NIH
  • Neurocritical care
  • Surrogate markers

Fingerprint Dive into the research topics of 'Clinical trial design in the neurocritical care unit'. Together they form a unique fingerprint.

  • Cite this

    Hall, C. E., Mirski, M., Palesch, Y. Y., Diringer, M. N., Qureshi, A. I., Robertson, C. S., Geocadin, R., Wijman, C. A. C., Le Roux, P. D., & Suarez, J. I. (2012). Clinical trial design in the neurocritical care unit. Neurocritical Care, 16(1), 6-19. https://doi.org/10.1007/s12028-011-9608-6